Saturday 17 October 2026
Export LFMD’s income statement to Excel — free account
LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
2.34
0.12
−4.88%
Follow LFMD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 6 | 8 | 5 |
| 913.95% | 144.18% | 34.95% | (69.60%) | ||
| (17.07%) | 15.35% | 3.56% | (4.35%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
90.99% | 88.55% | 58.54% | 116.73% | |
Average Days of Receivables |
20.23 | 17.50 | 18.61 | 21.44 | |
Free Cash Flow per Share |
0.07 | (0.03) | (0.08) | (0.38) | |
Free Cash Flow |
3.08 | (1.24) | (3.91) | (18.28) | |
Capital Expenditures |
(9.55) | (9.52) | (9.57) | (8.37) | |
| Other line items | |||||
Cash ROIC |
11.35% | (2.07%) | (7.91%) | (55.20%) | |
Accounts Receivable Turnover |
21.82 | 19.64 | 19.29 | 20.62 | |
Accounts Payable Turnover |
1.65 | 2.21 | 1.37 | 1.13 | |
Inventory Turnover |
9.60 | 9.95 | 8.30 | 7.72 | |
Average Days of Payables |
244.56 | 186.34 | 309.89 | 276.72 | |
Days of Inventory on Hand |
42.93 | 36.53 | 45.47 | 45.05 | |
Tax Rate |
0.09 | 0.06 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.77% | 3.79% | 3.77% | 3.78% | |
Selling, General and Administrative Expense of Revenue |
70.86% | 74.21% | 78.85% | 82.23% | |
Share Based Compensation of Revenue |
6.56% | 5.41% | 4.86% | 4.22% | |
Interest Coverage |
(4.72) | (3.79) | (10.25) | — | |
Operating CF/Net income |
(1.07) | 0.74 | 2.21 | 3.41 | |
Depreciation/Fixed assets |
3.12 | 3.09 | 3.43 | 3.88 | |
Capex/Depreciation |
(1.19) | (1.26) | (1.24) | (1.06) | |
Revenue per Share |
3.61 | 4.30 | 4.08 | 4.01 | |
Operating CF per Share |
0.27 | 0.18 | 0.12 | (0.21) | |
Capex per Share |
(0.21) | (0.21) | (0.20) | (0.18) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.04 |
Columns are period end dates